Laboratoires Vivacy
PrivateLast Round
Buyout/LBO
Nov 30, 2022
Est. Valuation
$891.55M
Total Funding Raised
$64.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Laboratoires Vivacy is a healthcare company that specializes in the development, manufacture, and distribution of hyaluronic acid-based injectable medical devices for aesthetic medicine, anti-aging, and viscosupplementation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Fashion & Beauty, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Laboratoires Vivacy Comparables
Compare Laboratoires Vivacy with similar companies based on industry and business-model similarity.
No public comparables are available for Laboratoires Vivacy. Request access to learn about comparables coverage.
Book a demoFor institutional investors. Book with your work email.
Laboratoires Vivacy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Nov 30, 2022 | ||||
| Buyout/LBO | Jan 1, 2019 | ||||
| Private Equity | Jul 15, 2015 | ||||
| Private Equity | Sep 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Laboratoires Vivacy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TA Associates | Buyout/LBO |
| Bridgepoint | Buyout/LBO |
| Initiative & Finance | Private Equity |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased from 0 to 76, representing 23% of headcount.
- Feb 21, 2026
Grew 24% QoQ, from 257 to 319 employees.
For institutional investors. Book with your work email.
Laboratoires Vivacy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Laboratoires Vivacy's valuation, stock price, and market status.
Is Laboratoires Vivacy a public or private company?
Laboratoires Vivacy is a private company.
What is the current stock price of Laboratoires Vivacy?
Laboratoires Vivacy is a private company, so its shares have no public market price. Caplight tracks Laboratoires Vivacy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Laboratoires Vivacy worth (valuation)?
Laboratoires Vivacy's valuation is estimated at $891.5M based on funding round data.
Can I buy Laboratoires Vivacy stock?
Laboratoires Vivacy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Laboratoires Vivacy's last funding round?
Laboratoires Vivacy's most recent funding round was Buyout/LBO on November 30, 2022.
Who are the main investors in Laboratoires Vivacy?
Key investors in Laboratoires Vivacy include TA Associates, Bridgepoint.
Will Laboratoires Vivacy IPO soon?
No public IPO plans have been announced for Laboratoires Vivacy.
How can I track Laboratoires Vivacy secondary market activity?
Caplight tracks bids, offers, and trades in Laboratoires Vivacy's shares on secondary markets.